Prof. Zhang Li
Chief Physician · Professor · Director of Medical Oncology
Academic Profile
Professor Zhang Li is Director of Medical Oncology and Chief Expert of Lung Cancer at Sun Yat-sen University Cancer Center — a leading thoracic oncologist in China. His immunotherapy and targeted-therapy studies are published in top journals and have changed clinical practice.
He is prolific in matched therapy for rare driver alterations (MET, RET and others) and immunotherapy biomarker research; patients can enroll in multiple globally synchronized studies through his team.
Appointments & Honors
- Director of Medical Oncology, SYSUCC
- Standing member, CSCO Immunotherapy Expert Committee
- Led 100+ international multicenter drug trials
Appointments
- Director, Medical Oncology, Sun Yat-sen University Cancer Center
- Member, Lung Cancer Committee, CACA
- Member, CSCO Immunotherapy Committee
Areas of Expertise
- Immunotherapy and targeted therapy for lung cancer
- Matched therapy for rare driver alterations
- Lung cancer study design
Academic Achievements
- Studies published in Lancet Oncology, JTO and other journals
- Advanced approvals of Chinese innovative agents in lung cancer
- National S&T Progress Award (2nd Class) recipient
Selected Publications
Ivonescimab combined with chemotherapy in EGFR-mutant NSCLC after progression on EGFR TKI (HARMONi-A)
JAMA · 2024
Corresponding author
Camrelizumab plus gemcitabine and cisplatin for recurrent or metastatic nasopharyngeal carcinoma (CAPTAIN-1st)
The Lancet Oncology · 2021
Corresponding author
Cancer Focus
Lung Cancer · Drug Development
Outpatient Schedule
| Wed AM · Specialist Clinic |
| Fri AM · VIP Clinic |
Schedules sync with the hospital’s official website daily at 00:00 CST. Actual availability is subject to the hospital’s same-day announcement.
Available Hospitals
Cancer Hospital, CAMS (National Cancer Center)
Beijing · Grade III-A · National Cancer Center
Shanghai Proton and Heavy Ion Center
Shanghai · Grade III Specialty · National Particle Therapy Flagship
Tianjin Medical University Cancer Institute & Hospital
Tianjin · Grade III-A · National Clinical Research Center
CASE FEASIBILITY REVIEW
Submit Your Case for a Free Review
Share your contact details, confirmed diagnosis and main question. No medical files needed at this stage. A clinical coordinator will contact you within 24-48 hours.
- No medical file upload required at this stage
- By submitting you agree to our privacy policy. Your information is used solely for hospital assessment and transmitted encrypted.